# Metformin and Esomeprazole For Preterm Pre-eclampsia

> **NCT05232994** · PHASE1 · UNKNOWN · sponsor: **Christiana Care Health Services** · enrollment: 38 (estimated)

## Conditions studied

- Preeclampsia Severe
- Preeclampsia Second Trimester
- Preterm Birth Complication

## Interventions

- **DRUG:** Esomeprazole 20mg

## Key facts

- **NCT ID:** NCT05232994
- **Lead sponsor:** Christiana Care Health Services
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05232994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05232994, "Metformin and Esomeprazole For Preterm Pre-eclampsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05232994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*